ABBOTT PARK, Ill., Nov. 30, 2016 /PRNewswire/ -- Abbott (NYSE: ABT) announced today its i-STAT ® Alinity™ System, an innovative, handheld blood testing platform, received CE Mark and is now for sale ...
The U.S. Food and Drug Administration recently approved a blood test that the U.S. Army Medical Materiel Development Activity at Fort Detrick worked on with Abbott Point of Care, which can more ...
- The test to help evaluate mild traumatic brain injury (TBI), commonly known as concussion, produces a result within 15 minutes after a plasma sample is inserted and will run on Abbott's i-STAT™ ...
The test measures glial fibrillary acidic protein and ubiquitin carboxyl-terminal hydrolase L1, biomarkers present in blood plasma at elevated concentrations after a brain injury. The Food and Drug ...
The US Food and Drug Administration (FDA) has approved the first rapid handheld blood test for suspected mild traumatic brain injury (TBI), the company has announced. The test yields results within 15 ...
VANCOUVER, British Columbia, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of a non-exclusive, ...
TAMPA, FL - OCTOBER 30: Tampa Bay Buccaneers wide receiver Russell Shepard (89) is checked for a concussion on the sideline by team doctors in the 4th quarter of the NFL game between the Oakland ...
ABBOTT PARK, Ill., April 1, 2024 /PRNewswire/ -- Abbott's i-STAT TBI cartridge has received clearance from the U.S. Food and Drug Administration (FDA) to be used with whole blood, allowing doctors to ...